Thalys Medical Technology Group Inc.

Shanghai Stock Exchange 603716.SS

Thalys Medical Technology Group Inc. Operating Income Margin for the year ending December 31, 2023: -8.99%

Thalys Medical Technology Group Inc. Operating Income Margin is -8.99% for the year ending December 31, 2023, a -634.70% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Thalys Medical Technology Group Inc. Operating Income Margin for the year ending December 31, 2022 was 1.68%, a -68.62% change year over year.
Thalys Medical Technology Group Inc. Operating Income Margin for the year ending December 31, 2021 was 5.36%, a -44.59% change year over year.
Thalys Medical Technology Group Inc. Operating Income Margin for the year ending December 31, 2020 was 9.67%, a -30.53% change year over year.
Thalys Medical Technology Group Inc. Operating Income Margin for the year ending December 31, 2019 was 13.92%, a 15.58% change year over year.

Key data

Date	Operating Income Margin	EBT Margin	Net Income Margin	EBITDA Margin

Shanghai Stock Exchange: 603716.SS

Thalys Medical Technology Group Inc.

CEO	Mr. Zheng Wang
IPO Date	Oct. 31, 2016
Location	China
Headquarters	1310 Jinshan Avenue
Employees	1,406
Sector	Health Care
Industries Pharmaceuticals Hospitals & Clinics

Description

Thalys Medical Technology Group Inc. engages in the medical intensive business and operation services in China. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Inc. in September 2020. Thalys Medical Technology Group Inc. was founded in 2004 and is headquartered in Wuhan, China.

Key trends

Past 5 years